* Aspira Women's Health Inc AWH.OQ reported a quarterly
adjusted
loss of 28 cents per share for the quarter ended in June,
identical to the same quarter last year. The mean expectation
of four analysts for the quarter was for a loss of 30 cents per
share. Wall Street expected results to range from -32 cents
to -29 cents per share.
* Revenue fell 2.7% to $2.42 million from a year ago;
analysts
expected $2.60 million.
* Aspira Women's Health Inc's reported EPS for the quarter
was a
loss of 28 cents.
* The company reported a quarterly loss of $3.53 million.
* Aspira Women's Health Inc shares had fallen by 23.5% this
quarter and lost 72.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"
Wall Street's median 12-month price target for Aspira Women's
Health Inc is $5.25
This summary was machine generated from LSEG data August 13 at
02:00 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.30 -0.28 Beat
Mar. 31 2024 -0.33 -0.39 Missed
Dec. 31 2023 -0.45 -0.30 Beat
Sep. 30 2023 -0.51 -0.48 Beat